You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
|
---|---|
Published in |
Translational Neurodegeneration, January 2023
|
DOI | 10.1186/s40035-023-00336-2 |
Pubmed ID | |
Authors |
Burak Yulug, Ozlem Altay, Xiangyu Li, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Hong Yang, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Ahmet Hacimuftuoglu, Serkan Yildirim, Muhammad Arif, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Hasan Turkez, Jan Borén, Mathias Uhlén, Adil Mardinoglu |
X Demographics
The data shown below were collected from the profiles of 184 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 39 | 21% |
United Kingdom | 14 | 8% |
Canada | 7 | 4% |
Australia | 4 | 2% |
Germany | 3 | 2% |
Poland | 2 | 1% |
South Africa | 2 | 1% |
Spain | 2 | 1% |
Andorra | 1 | <1% |
Other | 11 | 6% |
Unknown | 99 | 54% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 146 | 79% |
Practitioners (doctors, other healthcare professionals) | 18 | 10% |
Scientists | 17 | 9% |
Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 61 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 8% |
Student > Ph. D. Student | 4 | 7% |
Student > Master | 4 | 7% |
Student > Bachelor | 3 | 5% |
Professor | 3 | 5% |
Other | 9 | 15% |
Unknown | 33 | 54% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 6 | 10% |
Medicine and Dentistry | 5 | 8% |
Biochemistry, Genetics and Molecular Biology | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Agricultural and Biological Sciences | 2 | 3% |
Other | 5 | 8% |
Unknown | 38 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 178. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#232,474
of 25,848,962 outputs
Outputs from Translational Neurodegeneration
#10
of 397 outputs
Outputs of similar age
#5,904
of 478,440 outputs
Outputs of similar age from Translational Neurodegeneration
#1
of 16 outputs
Altmetric has tracked 25,848,962 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 397 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 478,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.